There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Mary Colella Autoimmune Disease Awareness Act of 2012

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To provide for the establishment of the Autoimmune Diseases Interdepartmental Coordinating Committee, and for other purposes.

Actions Overview (1)

07/26/2012Introduced in House

All Actions (3)

07/27/2012Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
07/26/2012Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
07/26/2012Introduced in House
Action By: House of Representatives

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce07/26/2012 Referred to
House Energy and Commerce Subcommittee on Health07/27/2012 Referred to

No related bill information was received for H.R.6218.

Latest Summary (1)

There is one summary for H.R.6218. View summaries

Shown Here:
Introduced in House (07/26/2012)

Mary Colella Autoimmune Disease Awareness Act of 2012 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish an Autoimmune Diseases Interdepartmental Coordinating Committee for the purpose of formulating recommendations for the coordination of governmental and private programs and activities relating to autoimmune diseases.

Requires the Coordinating Committee to: (1) develop criteria to be used in defining and identifying autoimmune diseases; (2) monitor federal, state, and private activities with respect to such diseases; (3) make recommendations regarding any appropriate changes to such activities, including recommendations to the Director of the National Institutes of Health (NIH) with respect to the development of a strategic plan for the coordination of governmental and private programs and activities relating to autoimmune diseases; (4) develop, annually update, and submit to Congress, biennially, such strategic plan; and (5) make recommendations regarding public participation in decisions relating to autoimmune diseases.